α1‐3/4 fucosylation at Asn 241 of β‐haptoglobin is a novel marker for colon cancer: A combinatorial approach for development of glycan biomarkers

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Cancer

• Publication date

  2012-05-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/ijc.26288PMID 21780104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia.

  2011cited by this paper
• alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.

  2010cited by this paper
• A systematic approach to protein glycosylation analysis: a path through the maze.

  2010cited by this paper
• N‐glycosylation status of β‐haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects

  2009cited by this paper
• Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry.

  2008cited by this paper
• Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells.

  2008cited by this paper
• Site‐specific analysis of N‐glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers

  2008cited by this paper
• Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects

  2008cited by this paper
• Fucosylated haptoglobin is a novel marker for pancreatic cancer: Detailed analyses of oligosaccharide structures

  2008cited by this paper
• Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.

  2007cited by this paper
• Analyzing the dynamic bacterial glycome with a lectin microarray approach

  2006cited by this paper
• Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon.

  2006cited by this paper
• Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

  2006cited by this paper
• Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

  2005cited by this paper
• Glycosylation defining cancer malignancy: New wine in an old bottle

  2002cited by this paper
• Fucosyltransferase III and sialyl-Lex expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue

  1996cited by this paper
• Biological and clinical significance of haptoglobin polymorphism in humans.

  1996cited by this paper
• A clinical study of lectin‐reactive alpha‐fetoprotein as an early indicator of hepatocellular carcinoma in the follow‐up of cirrhotic patients

  1995cited by this paper
• Expression and function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors.

  1995cited by this paper
• Expression and function of α2,3‐sialyl‐ and α,3/l,4‐fucosyltransferases in colon adenocarcinoma cell lines: Role in synthesis of E‐selectin counter‐receptors

  1995cited by this paper
• Haptoglobin. A potential reporter molecule for glycosylation changes in disease.

  1995cited by this paper
• Haptoglobin. A potential reporter molecule for glycosylation changes in disease.

  1995cited by this paper
• Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer.

  1995cited by this paper
• A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients

  1995cited by this paper
• The search for the ultimate screening test for hepatocellular carcinoma continues

  1994cited by this paper
• Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.

  1993cited by this paper
• Blood group‐related carbohydrate antigen expression in malignant and premalignant colonic neoplasms

  1992cited by this paper
• N-glycosylation of serum proteins in disease and its investigation using lectins.

  1992cited by this paper
• A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha(1,3/1,4)fucosyltransferase.

  1990cited by this paper
• Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.

  1987cited by this paper
• Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells.

  1986cited by this paper
• Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells.

  1986cited by this paper
• Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain.

  1984cited by this paper

• Fucosylated haptoglobin promotes inflammation via Mincle in sepsis: an observational study

  2025cites this paper
• Advancing rare cancer research by MALDI mass spectrometry imaging: Applications, challenges, and future perspectives in sarcoma

  2024cites this paper
• Development and validation of a model and nomogram for breast cancer diagnosis based on quantitative analysis of serum disease-specific haptoglobin N-glycosylation

  2024cites this paper
• Proteomics Approach to Identify Serum Biomarkers Associated with Gastric Cancer in South Indian Tamils.

  2024cites this paper
• The hidden potential of glycomarkers: Glycosylation studies in the service of cancer diagnosis and treatment.

  2023cites this paper
• Terminal fucosylation of haptoglobin in cancer-derived exosomes during cholangiocarcinoma progression

  2023cites this paper
• Haptoglobin polymorphism affects its N-glycosylation pattern in serum

  2022cites this paper
• Molecular markers in cancer.

  2022cites this paper
• In-depth investigation of altered glycosylation in human haptoglobin associated cancer by mass spectrometry.

  2021cites this paper
• [Haptoglobin as a biomarker].

  2021cites this paper
• Molecular Imaging of Ulex Europaeus Agglutinin in Colorectal Cancer Using Confocal Laser Endomicroscopy (With Video)

  2021cites this paper
• Anti-Cancer Potential of Afzelin towards AGS Gastric Cancer Cells

  2021cites this paper
• The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers

  2021cites this paper
• Haptoglobin as a Biomarker

  2021cites this paper
• Plant Lectins: Sugar-Binding Properties and Biotechnological Applications

  2020cites this paper
• Lectin Nanoconjugates for Targeted Therapeutic Applications

  2020cites this paper
• Haptoglobin: From hemoglobin scavenging to human health.

  2020cites this paper
• Glycosylation of serum haptoglobin as a marker of gastric cancer: an overview for clinicians

  2020cites this paper
• Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.

  2019cites this paper
• Establishment of an antibody specific for cancer-associated haptoglobin: a possible implication of clinical investigation

  2018cites this paper
• Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker

  2018cites this paper
• Characteristic glycopeptides associated with extreme human longevity identified through plasma glycoproteomics.

  2018cites this paper
• Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery

  2018cites this paper
• Cancer glycan epitopes: biosynthesis, structure and function.

  2018cites this paper
• Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.

  2017cites this paper
• Lectins: an effective tool for screening of potential cancer biomarkers

  2017cites this paper
• 2 Lectins : An Effective Tool for Screening of Potential Cancer 3 Biomarkers 4 5

  2017cites this paper
• Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer

  2016cites this paper
• Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC/MS and LC/MS/MS.

  2016cites this paper
• A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls

  2016cites this paper
• Multimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section.

  2016cites this paper
• Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer

  2016cites this paper
• Structural characterization and anti-inflammatory activity of two novel polysaccharides from the sea squirt, Ascidiella aspersa.

  2016cites this paper
• ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.

  2016cites this paper
• Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.

  2016cites this paper
• Insights on N-glycosylation of human haptoglobin and its association with cancers.

  2016cites this paper
• Utility of serum N -glycan analysis in diagnosis of invasive IPMNs

  2016cites this paper
• The Plasma Proteome of Children Recovering From Severe Malarial Anaemia

  2016cites this paper
• Integrins and haptoglobin: Molecules overexpressed in ovarian cancer.

  2015cites this paper
• Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.

  2015cites this paper
• Screening of enzymatic synthesis and expression of Lewis determinants in human colorectal carcinoma.

  2015cites this paper
• Engineering thermo-responsive affinity ligands for glycoprotein purification by affinity precipitation

  2015cites this paper
• Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer.

  2015cites this paper
• Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas.

  2015cites this paper
• Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis

  2014cites this paper
• Pinellia pedatisecta agglutinin-based lectin blot analysis distinguishes between glycosylation patterns in various cancer cell lines

  2014cites this paper
• Mass spectrometry-based analysis of glycoproteins and its clinical applications in cancer biomarker discovery

  2014cites this paper
• The role of glycosylation in IBD

  2014cites this paper
• Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer.

  2013cites this paper
• Quantitative Liquid Chromatography-Mass Spectrometry-Multiple Reaction Monitoring (LC-MS-MRM) Analysis of Site-specific Glycoforms of Haptoglobin in Liver Disease*

  2013cites this paper
• Trapping of Human Hemoglobin by Haptoglobin: Molecular Mechanisms and Clinical Applications

  2013cites this paper
• Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.

  2013cites this paper
• B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1

  2013cites this paper
• Gastric cancer: adding glycosylation to the equation.

  2013cites this paper
• Identification of a specific haptoglobin C‐terminal fragment in arthritic synovial fluid and its effect on interleukin‐6 expression

  2013cites this paper
• Transforming Growth Factor Beta Receptor 2 (TGFBR2) Changes Sialylation in the Microsatellite Unstable (MSI) Colorectal Cancer Cell Line HCT116

  2013cites this paper
• Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search.

  2012cites this paper
• Differences between the Glycosylation Patterns of Haptoglobin Isolated from Skin Scales and Plasma of Psoriatic Patients

  2012cites this paper
• Cancer Biomarker Discovery: Lectin-Based Strategies Targeting Glycoproteins

  2012cites this paper
• Biomarkers and their Role in Premonition, Interpretation and Treatment of Cancer

  2011cites this paper